LeMaitre Acquires Omniflow II Biologic Graft
August 18, 2014 at 10:15 AM EDT
LeMaitre Vascular, Inc. (Nasdaq: LMAT) acquired Xenotis, the manufacturer and marketer of the Omniflow II biological graft for ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.